AstraZeneca-Daiichi breast cancer drug Enhertu gets speedy USFDA nod Medical Dialogues Bureau22 Dec 2019 9:17 AM ISTAstraZeneca- Daiichi's drug Enhertu, also known as DS-8201, targets HER2 protein, a major trigger of uncontrolled cell growth in about 20% cases of...
Novartis wins Medicaid nod for new sickle cell drug Adakveo in 2 US states Medical Dialogues Bureau22 Dec 2019 9:00 AM ISTIn November, the U.S. Food and Drug Administration approved Adakveo and Global Blood Therapeutic Inc's Oxbryta, which carries a list price of $125,000...
Glenmark to launch Ryaltris in Australia via partner Seqirus Medical Dialogues Bureau21 Dec 2019 12:07 PM ISTThis paves the way for the launch of Ryaltris in Australia through our partner, Seqirus. Australia will be the first market globally where Ryaltris...
Lupin gets USFDA nod for generic version of Diprolene Ointment Farhat Nasim21 Dec 2019 9:40 AM ISTBetamethasone Dipropionate Ointment USP (Augmented), 0.05% is a generic version of Diprolene Ointment and will be manufactured at the company’s...
Suven Life Sciences Pashamylaram facility gets EIR from USFDA Farhat Nasim21 Dec 2019 9:30 AM ISTHyderabad: Suven Life Sciences Limited recently announced that the company has undergone the US health regulator's renewal inspection at their...
Novartis Zolgensma lottery-style giveaway upsets patient groups Medical Dialogues Bureau21 Dec 2019 9:15 AM ISTThe company's AveXis unit, which developed the drug- Zolgensma, will give out 50 doses of the treatment through June for babies under 2 years old,...
Indian Pharmacopoeia recognized by Afghanistan Medical Dialogues Bureau21 Dec 2019 9:00 AM ISTWith this, a new beginning has been made and Afghanistan has become the first country to recognize Indian Pharmacopoeia (IP) pursuant to the efforts...
Panacea Biotec wins Rs 170 crore Pentavalent vaccine orders from UN agencies Medical Dialogues Bureau20 Dec 2019 1:00 PM IST"Panacea Biotec... has received awards worth USD 24.32 million from U N agencies (Unicef and PAHO) for supply of its Easyfive-TT, a fully liquid WHO...
Lupin partner Concord gets USFDA nod for generic version of Myfortic tablets Medical Dialogues Bureau20 Dec 2019 12:59 PM ISTMycophenolic acid delayed-release tablet is a generic version of Novartis Pharmaceuticals Corporation's Myfortic delayed-release tablets in the same...
Sun Pharma arm-SPARC, Bioprojet ink licensing pact for auto-immune diseases drug SCD-044 Medical Dialogues Bureau20 Dec 2019 9:45 AM ISTSPARC and Bioprojet co-owned all SCD-044 related IP, developed through a research collaboration targeting Sphingosine-1-Phosphate Receptors to treat...
Merck Ebola vaccine Ervebo gets USFDA okay Medical Dialogues Bureau20 Dec 2019 9:30 AM ISTIn November, Merck received approval from the European Commission to market Ervebo, less than a month after a European medicines panel backed the...
FTC seeks to block Illumina from buying PacBio Medical Dialogues Bureau20 Dec 2019 9:00 AM ISTThe Federal Trade Commission said in a statement that it filed the antitrust complaint because of concern that Illumina wanted the deal in order to...
